Microfluidic-driven short peptides hydrogels with optical waveguiding property

Ana M. Garcia,Juan A. Garcia-Romero,Sara H. Mejias,Pilar Prieto,Vittorio Saggiomo,Aldrik H. Velders,M. Laura Soriano,Victor Ruiz-Díez,Juan Cabanillas-González,M. Victoria Gomez
DOI: https://doi.org/10.26434/chemrxiv-2023-x1hlv
2023-12-22
Abstract:Soft photonic elements with optical waveguiding ability based on biocompatible hydrogels have become increasingly important in optical techniques for medical diagnosis and phototherapy, among others. Supramolecular hydrogels based on peptides with interesting optical properties are rarely reported and explored. Although robust crystals based on short peptides have shown optical waveguiding capabilities, their rigidity is the main issue to overcome in the quest for soft biocompatible materials. Here, we report on a microfluidic-assisted formation of a heterochiral short peptide hydrogel that exhibit active optical waveguiding property thanks to the incorporation of two different dyes, Thioflavin T and Rhodamine B, in the hydrogel structure. Using our microfluidic platform, different parameters such as concentration of peptide, type of dye and its concentration, and flow rate have been rapidly explored, with remarkable low reagents consumption. In this way, it was possible to develop peptide hydrogel waveguides with good optical loss values, modulating the emission in diverse spectral regions. The use of microfluidics to prepare these hydrogels makes possible the preparation of structures of high length-to-diameter aspect ratio, which otherwise are hard to devise from bulk conditions. Overall, this work broadens the use of supramolecular self-assembly of peptides to create functional materials with additional versatility to polymeric hydrogels, thanks to the possibility of tuning structure by changing amino acids sequence. Additionally, the optical properties can be easily modulated by quick optimization of experimental parameters via microfluidic technology.
Chemistry
What problem does this paper attempt to address?
This paper mainly discusses the use of microfluidic technology to manufacture short peptide hydrogels to achieve optical waveguide properties. Traditional peptide-based photonic materials, such as crystalline structures, are limited in their application in biocompatible soft materials due to their rigidity. Researchers have formed a chiral short peptide hydrogel assisted by microfluidic approaches, which contains two different dyes (thioflavin T and rhodamine B) and exhibits active optical waveguide properties in its structure. By using a microfluidic platform, researchers rapidly explored different parameters such as peptide concentration, dye type and concentration, flow rate, etc., to achieve low reagent consumption and adjustable emission in different spectral regions. The research found that microfluidic technology enables the preparation of high aspect ratio structures that are difficult to achieve under traditional conditions. By adjusting the amino acid sequence, the structure of the supramolecular self-assembling short peptide hydrogel can be tuned. At the same time, by optimizing experimental parameters, its optical properties can be easily adjusted. In addition, compared to polymer hydrogels, short peptide hydrogels provide additional multifunctionality and can adjust the emission wavelength by changing the dye type and concentration to meet the requirements of optical-based medical diagnosis and treatment. The paper demonstrates the potential of microfluidic technology in the manufacturing of short peptide hydrogels with optical waveguide functionality, providing a new approach for the development of a new generation of biocompatible optical materials. By controlling flow rate, peptide concentration, and dye concentration, researchers can control the formation of short peptide hydrogels, optimize their optical losses, and achieve better light transmission performance. These findings are of great significance for the development of integrated biological optics and precise phototherapy applications.